Net profit of Sandu Pharmaceuticals declined 71.43% to Rs 0.06 crore in the quarter ended March 2012 as against Rs 0.21 crore during the previous quarter ended March 2011. Sales rose 77.87% to Rs 9.00 crore in the quarter ended March 2012 as against Rs 5.06 crore during the previous quarter ended March 2011.
For the unaudited full year, net profit rose 13.41% to Rs 0.93 crore in the year ended March 2012 as against Rs 0.82 crore during the previous year ended March 2011. Sales rose 45.81% to Rs 31.48 crore in the year ended March 2012 as against Rs 21.59 crore during the previous year ended March 2011.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2012 | Mar. 2011 | % Var. | Mar. 2012 | Mar. 2011 | % Var. |
| Sales | 9.00 | 5.06 | 78 | 31.48 | 21.59 | 46 |
| OPM % | 5.33 | 8.30 | -36 | 6.00 | 7.64 | -21 |
| PBDT | 0.36 | 0.40 | -10 | 1.51 | 1.44 | 5 |
| PBT | 0.21 | 0.30 | -30 | 1.08 | 1.07 | 1 |
| NP | 0.06 | 0.21 | -71 | 0.93 | 0.82 | 13 |